Serge Belanger
Stock Analyst at Needham
(4.67)
# 791
Out of 4,429 analysts
1024
Total ratings
48.1%
Success rate
12.6%
Average return
Main Sectors:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MLTX MoonLake Immunotherapeutics | Maintained: Buy | $30 | $21.22 | +41.38% | 25 | Jun 22, 2026 | |
| OCUL Ocular Therapeutix | Maintained: Buy | $18 | $10.12 | +77.95% | 14 | Jun 18, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $102 | $80.01 | +27.48% | 49 | Jun 16, 2026 | |
| HRTX Heron Therapeutics | Downgraded: Hold | n/a | $0.4186 | - | 61 | Jun 2, 2026 | |
| MANE Veradermics | Initiated Coverage: Buy | $136 | $103.60 | +31.27% | 1 | Jun 2, 2026 | |
| OCS Oculis Holding AG | Maintained: Buy | $46 → $38 | $11.72 | +224.23% | 8 | Jun 1, 2026 | |
| TRVI Trevi Therapeutics | Maintained: Buy | $23 | $17.40 | +32.22% | 50 | May 20, 2026 | |
| CRMD CorMedix | Maintained: Buy | $15 | $8.60 | +74.42% | 35 | May 14, 2026 | |
| OMER Omeros | Maintained: Hold | n/a | $10.48 | - | 52 | May 14, 2026 | |
| VRCA Verrica Pharmaceuticals | Rated: Hold | n/a | $5.65 | - | 47 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $3.16 | - | 40 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $34.62 | +61.76% | 167 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $70 | $74.04 | -5.46% | 71 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $19.58 | - | 43 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $78 | $54.61 | +42.83% | 39 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $26.27 | +37.04% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $48 | $31.46 | +52.57% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $16 | $9.31 | +71.86% | 56 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $17.28 | +85.19% | 34 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.74 | - | 29 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $32 | $23.51 | +36.11% | 78 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.11 | - | 48 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.10 | n/a | 9 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.8033 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.60 | n/a | 1 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.009 | n/a | 2 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $5 | $0.06505 | n/a | 3 | Aug 19, 2016 |
MoonLake Immunotherapeutics
Jun 22, 2026
Maintained: Buy
Price Target: $30
Current: $21.22
Upside: +41.38%
Ocular Therapeutix
Jun 18, 2026
Maintained: Buy
Price Target: $18
Current: $10.12
Upside: +77.95%
Cytokinetics
Jun 16, 2026
Maintained: Buy
Price Target: $102
Current: $80.01
Upside: +27.48%
Heron Therapeutics
Jun 2, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.4186
Upside: -
Veradermics
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $136
Current: $103.60
Upside: +31.27%
Oculis Holding AG
Jun 1, 2026
Maintained: Buy
Price Target: $46 → $38
Current: $11.72
Upside: +224.23%
Trevi Therapeutics
May 20, 2026
Maintained: Buy
Price Target: $23
Current: $17.40
Upside: +32.22%
CorMedix
May 14, 2026
Maintained: Buy
Price Target: $15
Current: $8.60
Upside: +74.42%
Omeros
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $10.48
Upside: -
Verrica Pharmaceuticals
May 13, 2026
Rated: Hold
Price Target: n/a
Current: $5.65
Upside: -
May 12, 2026
Maintained: Hold
Price Target: n/a
Current: $3.16
Upside: -
May 12, 2026
Maintained: Buy
Price Target: $56
Current: $34.62
Upside: +61.76%
May 11, 2026
Maintained: Buy
Price Target: $54 → $70
Current: $74.04
Upside: -5.46%
May 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $19.58
Upside: -
May 8, 2026
Maintained: Buy
Price Target: $80 → $78
Current: $54.61
Upside: +42.83%
May 7, 2026
Maintained: Buy
Price Target: $36
Current: $26.27
Upside: +37.04%
May 7, 2026
Maintained: Buy
Price Target: $48
Current: $31.46
Upside: +52.57%
May 6, 2026
Maintained: Buy
Price Target: $18 → $16
Current: $9.31
Upside: +71.86%
May 5, 2026
Maintained: Buy
Price Target: $32
Current: $17.28
Upside: +85.19%
May 5, 2026
Maintained: Hold
Price Target: n/a
Current: $6.74
Upside: -
May 1, 2026
Maintained: Buy
Price Target: $30 → $32
Current: $23.51
Upside: +36.11%
Dec 23, 2025
Rated: Hold
Price Target: n/a
Current: $0.11
Upside: -
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $1.10
Upside: n/a
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.8033
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $22
Current: $1.60
Upside: n/a
Jun 26, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.009
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $11 → $5
Current: $0.06505
Upside: n/a